Advancements in COVID-19 Testing: An In-depth Overview

Area of Science:

• Virology and Infectious Diseases
• Diagnostic Technologies
• Public Health

Background:

• The COVID-19 pandemic presented significant global health challenges, necessitating rapid development of diagnostic tools.
• Over a thousand commercial tests emerged, employing various sampling and detection methods for SARS-CoV-2.
• Accurate and timely diagnostics are vital for managing transmissions, especially with evolving viral strains.

Approach:

• This article reviews a wide spectrum of COVID-19 testing and screening methods.
• It covers nucleic acid amplification tests (NAAT), PCR, and isothermal detection techniques (RT-LAMP, RPA, NASBA, RCA, SDA, NEAR, TMA).
• Novel strategies including CRISPR, nanotechnology, metagenomic profiling, point-of-care tests, serological assays (ELISA), biomarker estimation, imaging (CT, MRI), microarrays, microfluidics, and AI are also discussed.

Key Points:

• The review emphasizes the importance of accurate testing and sampling for diagnosis, treatment, and management.
• It highlights the challenges posed by SARS-CoV-2 mutations and the need for adaptable diagnostic approaches.
• Advancements in testing strategies are crucial for controlling COVID-19 spread and its complications.

Conclusions:

• A comprehensive understanding of available and emerging diagnostic technologies is essential for effective pandemic response.
• The integration of diverse testing modalities, from molecular to AI-driven approaches, offers robust solutions for COVID-19 management.
• Continued innovation in diagnostic strategies is key to combating current and future infectious disease threats.